23andMe Licenses Its Own Drug Compound to Spanish Firm Almirall

(Bloomberg) -- 23andMe Inc., the Silicon Valley firm known for its ancestry DNA tests, has licensed an antibody it developed to treat inflammatory diseases to Spanish drugmaker Almirall SA.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.